Abstract:Quantitative glycogen determinations can be made in single blood and bone marrow cells, using microspectrophotometry or microfluorometry after staining with variants of the periodic acid--Schiff (PAS) reaction. These PAS variant reactions generally do not indicate the presence of non-glycogen PAS-positive substances, known to be prevalent in various hematopoietic cells, possibly due to masking of reactive groups. The specificity of the reaction in blood cells was ascertained by alpha-amylase digestion, which removed more than 95% of the PAS-positive material. Calibration of the PAS reaction was undertaken with a microdroplet model of pure leukocyte glycogen. The glycogen amounts in the droplets were determined by microinterferometry, the droplets were stained with a variant PAS reaction, and the total extinction of the reaction product in the stained droplets was determined by microspectrophotometry. The extinction coefficient (k) was obtained from the equation k equals Etot divided by M where (Etot) is the total extinction as determined by microspectrophotometry and (M) the dry glycogen amount as determined by microinterferometry. The microinterferometric dry mass determinations were calibrated by X-ray absorption in order to obtain the absolute amounts of glycogen. For practical purposes a reference system was made of normal neutrophil leukocytes. The glycogen content in the reference neutrophils was first determined with the micromodel. These neutrophils, now with a known glycogen amount, were stained with the PAS reagents and measured microspectrophotometrically in parallel with cells containing an unknown glycogen amount. Alternatively, the staining was made with a fluorescent PAS reaction, and the glycogen content determined by microfluorometry. Both methods appeared suitable for determining the glycogen content of blood cells from patients with various diseases, though the microfluorometric method was preferable for measurements of small amounts of inhomogeneously distributed glycogen. The mean glycogen content of normal neutrophil leukocytes was found to be 13.6 times 10(-12) g. The content was increased in infectious diseases such as pneumonia and tonisillitis, as well as in polycythemia vera and myelofibrosis, while low amounts were found in untreated chronic myelocytic leukemia. In chronic myelocytic leukemia in remission, the glycogen content of mature neutrophils had completely normalized. Erythroblasts normally do not contain detectable amounts of glycogen. However, in certain diseases such as beta-thalassemia and Di Guglielomo's syndrome, appreciable amounts of glycogen accumulate in the erythropoietic precursor cells. In beta-thalassemia this was associated with an arrest in the proliferation of early polychromatic erythroblasts, which accumulate glycogen in the G1 phase of the cell cycle. In all these diseases quantitative glycogen determinations in the blood cells have diagnostic importance.

Determination of glycogen by Rayleigh light scattering

A study on the interaction between concanavalin A and glycogen by light scattering technique and its analytical application

Selective enhancement of resonance light-scattering of gold nanoparticles by glycogen.

Rapid discrimination of glycogen particles originated from different eukaryotic organisms

Quantitative cytochemistry of glycogen in blood cells. Methods and clinical application

NOVEL METHOD FOR DETECTION OF GLYCOGEN IN CELLS

Gold nanoparticle based plasmon resonance light-scattering method as a new approach for glycogen-biomacromolecule interactions.

Research Progress of Glycogen Detection Methods

Analysis of Cell Glycogen with Quantitation and Determination of Branching Using Liquid Chromatography-Mass Spectrometry

The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination

Molecular structure of glycogen in diabetic liver

Molecular Structure of Human-Liver Glycogen

“Fluorescent glycogen” formation with sensibility for in vivo and in vitro detection

A Bioluminescent Assay for Quantification of Cellular Glycogen Levels

Identification of Structural Stability and Fragility of Mouse Liver Glycogen Via Label-Free Raman Spectroscopy Coupled with Convolutional Neural Network Algorithm

Molecular Structure of Glycogen in Escherichia coli

Sensitive quantification of α-glucans in mouse tissues, cell cultures, and human cerebrospinal fluid

Heterozygote-diagnosis of GSD II and GSD III by quantitation of a urinary glycogen fragment: 1

Determination of Albumin and Globulin at Nanogram Levels by a Resonance Light-Scattering Technique with α,β, γ, δ -Tetrakis(4-sulfophenyl)porphine

Determination of nucleic acids in acidic medium by enhanced light scattering of large particles.

Using molecular fine structure to identify optimal methods of extracting fungal glycogen